1. Home
  2. CTMX vs USEG Comparison

CTMX vs USEG Comparison

Compare CTMX & USEG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTMX
  • USEG
  • Stock Information
  • Founded
  • CTMX 2008
  • USEG 1966
  • Country
  • CTMX United States
  • USEG United States
  • Employees
  • CTMX 122
  • USEG N/A
  • Industry
  • CTMX Biotechnology: Pharmaceutical Preparations
  • USEG Oil & Gas Production
  • Sector
  • CTMX Health Care
  • USEG Energy
  • Exchange
  • CTMX Nasdaq
  • USEG Nasdaq
  • Market Cap
  • CTMX 62.3M
  • USEG 80.1M
  • IPO Year
  • CTMX 2015
  • USEG N/A
  • Fundamental
  • Price
  • CTMX $0.80
  • USEG $2.03
  • Analyst Decision
  • CTMX Buy
  • USEG Strong Buy
  • Analyst Count
  • CTMX 6
  • USEG 2
  • Target Price
  • CTMX $5.77
  • USEG $2.75
  • AVG Volume (30 Days)
  • CTMX 730.8K
  • USEG 11.5M
  • Earning Date
  • CTMX 03-10-2025
  • USEG 03-25-2025
  • Dividend Yield
  • CTMX N/A
  • USEG N/A
  • EPS Growth
  • CTMX N/A
  • USEG N/A
  • EPS
  • CTMX 0.16
  • USEG N/A
  • Revenue
  • CTMX $126,617,000.00
  • USEG $22,257,000.00
  • Revenue This Year
  • CTMX $22.55
  • USEG N/A
  • Revenue Next Year
  • CTMX N/A
  • USEG $12.17
  • P/E Ratio
  • CTMX $5.14
  • USEG N/A
  • Revenue Growth
  • CTMX 33.66
  • USEG N/A
  • 52 Week Low
  • CTMX $0.75
  • USEG $0.81
  • 52 Week High
  • CTMX $5.85
  • USEG $6.40
  • Technical
  • Relative Strength Index (RSI)
  • CTMX 41.61
  • USEG 46.00
  • Support Level
  • CTMX $0.75
  • USEG $2.13
  • Resistance Level
  • CTMX $0.98
  • USEG $3.56
  • Average True Range (ATR)
  • CTMX 0.06
  • USEG 0.26
  • MACD
  • CTMX 0.00
  • USEG -0.08
  • Stochastic Oscillator
  • CTMX 20.13
  • USEG 4.37

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc is an oncology-focused biopharmaceutical company that is operating in the United States. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

About USEG U.S. Energy Corp. (DE)

US Energy Corp is an independent energy company. It is focused on the acquisition and development of oil and natural gas-producing properties in the continental United States. It has business activities in South Texas and the Williston Basin in North Dakota. The company generates revenue from its interest in the sales of oil and natural gas production.

Share on Social Networks: